Management of Chest Pain in Patients with Coronary Artery Disease
Sublingual nitroglycerin should be administered immediately for acute relief of chest pain in patients with coronary artery disease (CAD). 1
First-Line Treatment for Acute Chest Pain in CAD
Immediate Management
- Sublingual nitroglycerin (0.3-0.4 mg) should be administered every 5 minutes for up to 3 doses 2
- After 3 doses, assess the need for intravenous nitroglycerin if pain persists and there are no contraindications 2
- For persistent ischemia, heart failure, or hypertension, intravenous nitroglycerin is indicated 2
Important Contraindications
- Do not administer nitroglycerin if patient has recently taken phosphodiesterase inhibitors:
- Within 24 hours of sildenafil or vardenafil
- Within 48 hours of tadalafil 2
- Nitroglycerin is contraindicated in patients with hypertrophic obstructive cardiomyopathy 2
Second-Line Treatments
If chest pain persists despite nitroglycerin:
Beta-Blockers
- Initiate oral beta-blockers within 24 hours if no contraindications exist (heart failure, low-output state, risk for cardiogenic shock) 2
- Preferred agents for CAD with heart failure: metoprolol succinate, carvedilol, or bisoprolol 2, 3
- Avoid intravenous beta-blockers when risk factors for shock are present 2
Calcium Channel Blockers (CCBs)
- Use non-dihydropyridine CCBs (verapamil, diltiazem) for recurrent ischemia when:
- Beta-blockers are contraindicated
- No left ventricular dysfunction exists
- No increased risk for cardiogenic shock 2
- For coronary artery spasm, long-acting CCBs and nitrates are recommended 2
- Important caution: Immediate-release nifedipine is contraindicated without concurrent beta-blocker therapy 2
Special Considerations
For Vasospastic Angina
- First-line: Calcium channel blockers (e.g., verapamil 40 mg BID, uptitrated as needed)
- Second-line: Add long-acting nitrate (e.g., isosorbide mononitrate 10 mg BID)
- Third-line: Consider nicorandil if available 2
For Microvascular Angina
- Beta-blockers (e.g., carvedilol 6.25 mg BID, uptitrated as needed) 2
- Sublingual nitroglycerin as needed for acute symptoms 2
Common Pitfalls and Caveats
Do not rely on nitroglycerin response for diagnosis: Relief of chest pain with nitroglycerin does not reliably distinguish between cardiac and non-cardiac chest pain 4, 5. In one study, nitroglycerin relieved chest pain in 35% of patients with active CAD and 41% of patients without active CAD 4.
Patient education is critical: Many CAD patients (37% in one study) are not prescribed sublingual nitroglycerin despite guidelines recommending it, and only 43% of those prescribed receive proper instruction 6. Ensure patients:
- Keep nitroglycerin available at all times
- Know to call emergency services if chest pain is unrelieved after 3 doses
Consider intravenous nitroglycerin for refractory angina: For patients with chest pain refractory to multiple doses of sublingual nitroglycerin, intravenous nitroglycerin can be effective in approximately 85% of cases 7.
NSAIDs (except aspirin) should be discontinued during management of chest pain in CAD patients due to increased risk of major adverse cardiac events 2.
By following this evidence-based approach to chest pain management in CAD patients, clinicians can effectively relieve symptoms while reducing morbidity and mortality associated with coronary ischemia.